Bunkerhill ECG-EF vs OPTIS Mobile Next Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS

AI Verdict

Tool A, Bunkerhill ECG-EF, is a software-only diagnostic tool that uses AI to detect reduced left ventricular ejection fraction from routine ECGs, aiding in early heart failure risk identification. In contrast, Tool B, OPTIS Mobile Next Imaging, is an AI-powered mobile hardware system for intravascular imaging and coronary physiology measurements, specifically designed to guide PCI procedures in cath labs. While both are cardiology AI tools, they address distinct clinical needs: diagnosis and risk assessment versus interventional guidance.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is the early and non-invasive identification of patients at risk for heart failure within a general clinical setting. This AI algorithm efficiently analyzes routine 12-lead ECGs to detect reduced Left Ventricular Ejection Fraction (LVEF ≤ 40%), seamlessly integrating with EHRs for broad screening and automated clinical workflows.

View Bunkerhill ECG-EF →

Choose OPTIS Mobile Next Imaging if…

Choose OPTIS Mobile Next Imaging if you require advanced, AI-powered intravascular imaging and coronary physiology measurements to precisely guide percutaneous coronary intervention (PCI) procedures in a catheterization laboratory. This transportable system offers high-resolution OCT and RFR/FFR data, enabling enhanced efficiency and informed decision-making during complex interventional cardiology cases.

View OPTIS Mobile Next Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF OPTIS Mobile Next Imaging
Pricing Contact sales for pricing details. Unknown
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. On-premise (mobile cart system integrated into catheterization laboratories)
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill ECG-EF

Bunkerhill ECG-EF is a software-only solution that integrates seamlessly with existing EHRs and clinical archives, leveraging routine and widely available ECG data for broad-scale screening. This approach offers a significantly lower barrier to adoption and ease of use for a wider range of clinicians. In contrast, OPTIS Mobile Next Imaging is a specialized physical device requiring invasive procedures and expert personnel in a cath lab setting.

Clinical Value

Tie

Both tools offer high clinical value in distinct areas of cardiology. Bunkerhill ECG-EF provides accessible, early screening for heart failure risk using routine ECGs, potentially leading to earlier intervention for a broad patient population. OPTIS Mobile Next Imaging offers real-time, high-resolution imaging and physiological measurements to guide complex PCI procedures, directly improving procedural outcomes and decision-making in interventional cardiology.

Pricing & Value

Bunkerhill ECG-EF

While both tools require contacting the vendor for exact pricing, OPTIS Mobile Next Imaging involves a significant capital expenditure for a physical imaging system and ongoing costs for disposable catheters. Bunkerhill ECG-EF, being a software-only solution integrated into existing EHRs, is likely to have a subscription-based model with a lower initial investment and potentially more predictable operational costs, offering better value transparency in its deployment model.

Enterprise Readiness

Bunkerhill ECG-EF

Bunkerhill ECG-EF explicitly states BAA and HIPAA compliance, along with FDA clearance, and provides evidence of robust security certifications (SOC 2 Type II, ISO 27001:2022). Its seamless integration with EHRs and its platform approach (Carebricks) for building and deploying AI workflows demonstrate a higher level of enterprise readiness and adaptability. OPTIS Mobile Next Imaging's BAA and HIPAA compliance are described as 'likely' or 'responsibility lies with the provider,' making it less definitive.

Innovation

Bunkerhill ECG-EF

While both are innovative, Bunkerhill ECG-EF stands out by leveraging routine 12-lead ECGs for early, non-invasive detection of reduced LVEF, making advanced diagnostics more accessible and scalable. Furthermore, its underlying Carebricks platform, which uses generative AI for clinical reasoning and action across various data sources and enables rapid deployment of custom AI workflows, represents a broader and more foundational innovation in healthcare AI.

Support & Docs

OPTIS Mobile Next Imaging

Abbott Medical, as a large and established medical device company, provides comprehensive and easily accessible customer service, technical support, and extensive documentation (user manuals, IFUs) for its products, including the OPTIS Mobile Next Imaging System. Bunkerhill Health, while having a contact page, does not provide specific details on support channels or publicly available documentation for ECG-EF.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF OPTIS Mobile Next Imaging
Name Bunkerhill ECG-EF OPTIS Mobile Next Imaging
Company BunkerHill Health Abbott Medical
Description/Purpose An FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. An AI-powered, transportable intravascular imaging system for cath labs, offering high-resolution OCT and coronary physiology measurements to guide PCI procedures with enhanced efficiency and informed decision-making.
Primary Technology/Method AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECG data. AI-powered Optical Coherence Tomography (OCT) intravascular imaging and coronary physiology measurements (RFR/FFR).
Target Clinical Use Aids in early identification of patients at risk for heart failure. Guides PCI procedures with enhanced efficiency and informed decision-making.
Data Input Routine 12-lead electrocardiograms (ECGs) Intravascular imaging (OCT) and coronary physiology measurements (RFR/FFR)

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and OPTIS Mobile Next Imaging.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an AI algorithm designed for the early identification of patients at risk for heart failure by detecting reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs. In contrast, OPTIS Mobile Next Imaging is an AI-powered intravascular imaging system that provides high-resolution Optical Coherence Tomography (OCT) and coronary physiology measurements to guide Percutaneous Coronary Intervention (PCI) procedures in cath labs.
Bunkerhill ECG-EF is a software-only medical device that integrates seamlessly with Electronic Health Records (EHRs) and clinical archives, supporting automated clinical workflows. OPTIS Mobile Next Imaging is a transportable mobile cart system designed for on-premise use in catheterization laboratories, offering seamless and secure integration with cath lab IT systems and DICOM.
Bunkerhill ECG-EF analyzes routine 12-lead electrocardiogram (ECG) data to identify signs of reduced LVEF. OPTIS Mobile Next Imaging utilizes Optical Coherence Tomography (OCT) intravascular imaging and coronary physiology measurements, such as RFR/FFR, to assess coronary arteries and guide PCI.
Bunkerhill ECG-EF is designed for use across Cardiology, Emergency Medicine, and Internal Medicine, aiding in the early identification of heart failure risk in a broad patient population. OPTIS Mobile Next Imaging is primarily utilized within Cardiology, specifically for interventional cardiologists in catheterization laboratories to guide PCI procedures.
Bunkerhill ECG-EF is a non-invasive, software-only medical device that analyzes existing ECG data. In contrast, OPTIS Mobile Next Imaging involves intravascular imaging, which is an invasive procedure performed within a catheterization laboratory.
Bunkerhill ECG-EF aids in clinical decision-making by providing a rapid and accessible method for early identification of patients at risk for heart failure, prompting further cardiac evaluation. OPTIS Mobile Next Imaging enhances informed decision-making during PCI procedures by offering high-resolution intravascular imaging and coronary physiology measurements, streamlining the workflow and optimizing outcomes.
AI Tool Finder
AI-powered search. Results may not be comprehensive.